New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).
about
Insulin glargine 300 U/mL in the management of diabetes: clinical utility and patient perspectivesrDNA insulin glargine U300 - a critical appraisalPharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance.Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus.Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL: one-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes.Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study.Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL.The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis.Challenges and unmet needs in basal insulin therapy: lessons from the Asian experience.Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study.Understanding concentrated insulins: a systematic review of randomized controlled trials.Cardiovascular safety of long-acting insulin analogs in type 2 diabetes patients: Is there a better basal insulin?Open-label, randomized study comparing basal insulin peglispro and insulin glargine, in combination with oral antihyperglycemic medications, in insulin-naïve Asian patients with type 2 diabetes.Clinical Challenges With Concentrated Insulins: Setting the Record Straight.Ease of Use of the Insulin Glargine 300 U/mL Pen Injector in Insulin-Naïve People With Type 2 Diabetes.Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature.Conversion from insulin glargine U-100 to insulin glargine U-300 or insulin degludec and the impact on dosage requirements.Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes.Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.Basal-Bolus Insulin Therapy with Gla-300 During Hospitalization Reduces Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Study.A comparison of the clinical courses of type 2 diabetic patients whose basal insulin preparation was replaced from insulin glargine 100 units/mL to insulin glargine biosimilar or 300 units/mL: a propensity score-matched observation study
P2860
Q28074690-3938460D-CD99-4FF9-9B2E-E78439A46369Q28077366-2A3FE51F-4378-4D1D-8576-E0C2761B3398Q30248803-78B2F7D6-25B4-4F6B-83A2-5EEAC10226EBQ33884391-617F4F03-0788-4935-9102-652558372273Q38597991-E734639F-15EC-4403-AE7D-B65A709DFBAEQ38858785-85F606A5-038A-4AA8-BEED-FF868152314AQ38971612-4BF9E35E-2518-4706-81E8-B51153BA4EDCQ47117670-F033E734-27CD-438B-A068-826F7EE67344Q47149556-3183FEC0-D722-4A11-8B07-97D3762D56AAQ47192711-BE3B6C1C-7121-4079-B9AD-8C616C5ECD62Q47322851-A7EEF08B-BCFC-492D-91BF-A94286A4F1DDQ48300108-09C2CA70-7BE2-4EF6-9AD0-2FC0790C138EQ49365317-CF1DA4D0-1CE0-4AC6-BD81-38AD58242FF5Q49899781-E6497B03-072B-423B-B930-F7CE9A80F439Q50351384-A88D14C8-75A1-49CA-AA85-F050BD8D873EQ52605864-62092C93-A0C2-4EC8-B3A6-F36CCAF5E534Q52606010-4B9CFAA3-55A6-48C9-9E89-478554418EC0Q53448284-C3451567-FE69-4EDA-A72B-49B6A429A4DEQ55046951-2D7438DA-2C6E-422C-AFE0-78C83533BF40Q55078513-E696461A-BA4C-4100-AF08-86FD3855BFBDQ58763121-3A6581B1-876A-4501-967C-DECA2FE49C8E
P2860
New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New insulin glargine 300 U/ml ...... ntrolled trial (EDITION JP 2).
@en
New insulin glargine 300 U/ml ...... a randomized controlled trial
@nl
type
label
New insulin glargine 300 U/ml ...... ntrolled trial (EDITION JP 2).
@en
New insulin glargine 300 U/ml ...... a randomized controlled trial
@nl
prefLabel
New insulin glargine 300 U/ml ...... ntrolled trial (EDITION JP 2).
@en
New insulin glargine 300 U/ml ...... a randomized controlled trial
@nl
P2093
P2860
P921
P356
P1476
New insulin glargine 300 U/ml ...... ntrolled trial (EDITION JP 2).
@en
P2093
M C Riddle
Y Takahashi
Y Terauchi
P2860
P304
P356
10.1111/DOM.12618
P577
2015-12-11T00:00:00Z